The vast majority (89%) of those who attempted to get an in-person COVID-19 test in the past month say they were able to get one. Still 11% of those who tried to get such a test (4% of all adults) say they were unable to get an in-person test, and 23% (7% of all adults) say they had to wait two days or more to be tested.
Source: Kaiser Family Foundation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
